Pfizer/BioNTech Seeks US Nod for Child COVID Vaccine as Booster

Pfizer and BioNTech have applied for emergency use authorization of their Omicron-adapted COVID-19 vaccine in the United States as a booster dose for children aged 6 months through 4 years, the companies announced.
Reuters Health Information

source https://www.medscape.com/viewarticle/988925?src=rss